Chemokine Systems and Hepatitis C Virus Infection: Is Truth in the Genes of the Beholders?

Hepatology

Volumn 38, Issue 6, 2003, Pages 1359-1362

  Promrat, Kittichai ^a   Liang, T Jake ^b  

^a BROWN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERFERON;

ALLELE; DISEASE PREDISPOSITION; DRUG EFFECT; EDITORIAL; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; INFECTION SENSITIVITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0345448984     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hep.2003.10.008     Document Type: Editorial

References (19)

1. Cooke GS, Hill AV. Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001;2:967-977.
2. Thio CL, Thomas DL, Carrington M. Chronic viral hepatitis and the human genome. HEPATOLOGY 2000;31:819-827.
3. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC. influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 1999;354:2119-2124.
4. Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, et al. HLA-Cw*04 and hepatitis C virus persistence. J Virol 2002;76:4792-4797.
5. Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. HEPATOLOGY 2001;33:708-712.
6. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM, et al. Host genetic factors influence disease progression in chronic hepatitis C. HEPATOLOGY 2000;31:828-833.
7. Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, et al. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. HEPATOLOGY 2003;37:65-71.
8. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445.
9. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999;163:6236-6243.
10. Kusano F, Tanaka Y, Marumo F, Sato C. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab Invest 2000;80:415-422.
11. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Sargosti S, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-725.
12. Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, et al. Frequency of the HIV-protective CC chemokine receptor 5-Δ32/Δ32 genotype is increased in hepatitis C. Gastroenterology 2002;122:1721-1728.
13. Zhang M, Goedert JJ, O'brien TR. High frequency of CCR5-delta32 homozygosity in HCV-infected, HIV-1-uninfected hemophiliacs results from resistance to HIV-1. Gastroenterology 2003;124:867-868.
14. Promrar K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, et al. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 2003;124:352-360.
15. Mangia A, Santoro R, D'agruma L, Andriulli A. HCV chronic infection and CCR5-delta32/delta32. Gastroenterology 2003;124:868-869.
16. Dorak MT, Folayan GO, Niwas S, van Leeuwen DJ, Yee LJ, Tang J, Kaslow RA. C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection. Immunol Res 2002;26:167-175.
17. Hellier S, Frodsham AJ, Hennig BJ, Klenerman P, Knapp S, Ramaley P, Satsangi J, et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands RANTES and MCP-2 with outcome of HCV infection. HEPATOLOGY 2003;38:1468-1476.
18. Schwabe RF, Bataller R, Brenner DA. Human Hepatic Stellate Cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol 2003;285:G949-G958.
19. Gonzalez E, Bamshad M, Sato N, Mummidi S, Dhanda R, Catano G, Cabrera S, et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A 1999;96:12004-12009.